The South Korea clinical nutrition market size reached USD 1,063.45 Million in 2024. Looking forward, the market is expected to reach USD 1,979.92 Million by 2033, exhibiting a growth rate (CAGR) of 7.15% during 2025-2033. The market is expanding rapidly, driven by heightened awareness about nutrition's role in managing lifestyle and chronic diseases, and aging demographics boosting demand for tailored enteral and parenteral therapies. Innovations in personalized formulations and stronger hospital-level adoption further enhance access to clinical nutritional support. These trends collectively strengthen the South Korea clinical nutrition market share.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 1,063.45 Million |
Market Forecast in 2033 | USD 1,979.92 Million |
Market Growth Rate 2025-2033 | 7.15% |
Aging Population & Rising Chronic Disease Prevalence
South Korea’s rapidly aging demographic, combined with the increasing incidence of chronic conditions such as obesity, diabetes, cardiovascular disorders, hypertension, and osteoporosis, is a key market driver. As more seniors and urban adults require nutrition therapy alongside clinical interventions, demand grows for enteral and parenteral formulas supporting long-term disease management, recovery protocols, and healthy aging. Preventive and therapeutic nutritional solutions are increasingly adopted within hospitals and care facilities to mitigate comorbidity risk and enhance patient outcomes. Government health campaigns and institutional nutrition strategies further reinforce recognition of clinical nutrition’s role in curbing escalating lifestyle-related disease burden, elevating its relevance in South Korea’s evolving healthcare ecosystem.
Awareness of Nutrition’s Role in Preventive Care & Functional Foods Adoption
The growing consumer consciousness around the health benefits of targeted nutrition, particularly in managing or preventing chronic conditions, has fueled the adoption of medical nutrition products, which is boosting the South Korea clinical nutrition market growth. Alongside this, South Korea’s functional food and health supplement culture aligns closely with preventive wellness goals. Clinical nutrition products that combine therapeutic benefits with palatability and convenience are increasingly accepted in hospital settings and outpatient care. Policies and public health initiatives that promote balanced diets and nutritional education also contribute to greater acceptance of clinical nutrition solutions. This trend enhances trust in enteral and parenteral formulations as viable adjuncts to medication, supporting their integration into both inpatient and domiciliary care settings.
Technological & Healthcare Infrastructure Advancements
South Korea's highly advanced healthcare system and robust infrastructure provide strong support for clinical nutrition adoption. Modern hospitals, widespread clinical nutrition protocols, and government-backed nutritional programs facilitate widespread implementation of enteral and parenteral therapies. Additionally, innovations in personalized nutrition—powered by technologies like AI, big data analytics, and genetic assessment—enable customized nutrition solutions tailored to specific patient conditions. These technological capabilities boost prescription precision and clinical acceptance. Within this regulated, technologically sophisticated environment, both domestic and global firms are increasingly launching clinical nutrition products and therapies, supported by streamlined approvals and collaborative research across academic–medical industry partnerships. This robust ecosystem reinforces market growth and product penetration.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on product, route of administration, application, and end user.
Product Insights:
The report has provided a detailed breakup and analysis of the market based on product. This includes infant nutrition, parental nutrition, and enteral nutrition.
Route of Administration Insights:
A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes oral, enteral, and parenteral.
Application Insights:
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes cancer, malnutrition, metabolic disorders, gastrointestinal disorders, neurological disorders, and others.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes pediatric, adults, and geriatric.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), and others.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Products Covered | Infant Nutrition, Parental Nutrition, Enteral Nutrition |
Route of Administrations Covered | Oral, Enteral, Parenteral |
Applications Covered | Cancer, Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, Others |
End Users Covered | Pediatric, Adults, Geriatric |
Regions Covered | Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), Others |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: